These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 11680592
1. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas. Lee KT, Liu TS. Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592 [Abstract] [Full Text] [Related]
5. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Ishikawa A, Sasaki M, Ohira S, Ohta T, Oda K, Nimura Y, Chen MF, Jan YY, Yeh TS, Nakanuma Y. Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136 [Abstract] [Full Text] [Related]
6. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Sasaki M, Nakanuma Y, Ho SB, Kim YS. Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202 [Abstract] [Full Text] [Related]
7. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma. Lee KT, Liu TS. World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766 [Abstract] [Full Text] [Related]
8. The expression of MUC mucin in cholangiocarcinoma. Mall AS, Tyler MG, Ho SB, Krige JE, Kahn D, Spearman W, Myer L, Govender D. Pathol Res Pract; 2010 Dec 15; 206(12):805-9. PubMed ID: 20947262 [Abstract] [Full Text] [Related]
9. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M. Hum Pathol; 2007 Dec 15; 38(12):1819-25. PubMed ID: 17854859 [Abstract] [Full Text] [Related]
10. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Sasaki M, Nakanuma Y, Kim YS. Hepatology; 1998 Jan 15; 27(1):54-61. PubMed ID: 9425917 [Abstract] [Full Text] [Related]
11. Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct. Lee KT, Sheen PC. J Surg Oncol; 1995 Jun 15; 59(2):131-5. PubMed ID: 7776654 [Abstract] [Full Text] [Related]
12. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS. Oncol Rep; 2009 Sep 15; 22(3):649-57. PubMed ID: 19639217 [Abstract] [Full Text] [Related]
19. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Shimonishi T, Zen Y, Chen TC, Chen MF, Jan YY, Yeh TS, Nimura Y, Nakanuma Y. Hum Pathol; 2002 May 15; 33(5):503-11. PubMed ID: 12094375 [Abstract] [Full Text] [Related]
20. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W. Hum Pathol; 2010 Nov 15; 41(11):1558-65. PubMed ID: 20621328 [Abstract] [Full Text] [Related] Page: [Next] [New Search]